2022 annual financial data
Adial Pharmaceuticals 2022 Financial results
Direct answer
Revenue was 0 USD.
Operating income was -10,859,475 USD and net income was -12,731,416 USD.
Operating cash flow was -11,185,985 USD.
Get free Adial Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -10,859,475 USD
- Net income
- -12,731,416 USD
- Operating cash flow
- -11,185,985 USD
Explore related company data
View all 2022 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Net marginView Operating cash flow marginView all Adial Pharmaceuticals financial years